Table 5. Rate of response to ovarian cancer treatment, stratified by dose level.
Group (mg/m2) | Total No. of cycles | Investigator evaluation | Best overall response (reviewer evaluation) |
---|---|---|---|
220 | 6 | PR | PR |
6 | CR | PR | |
6 | PR | PR | |
2 | PR | PR | |
6 | CR | PR | |
6 | PR | PR | |
260 | 6 | PR | PR |
6 | PR | PR | |
6 | PR | PR | |
2 | PD | PD | |
6 | CR | PR | |
6 | CR | CR | |
300 | 1 | NA | NA |
6 | PR | PR | |
2 | PR | PR | |
6 | CR | CR | |
6 | CR | PR | |
6 | PR | PR |
CR, complete response; NA, not available; PD, progressive disease; PR, partial response.